Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Shawn Lee, MD, PhD, an AACR-St. Baldrick’s Foundation Grantee, is working to personalize therapies for children with acute lymphoblastic...
Laura M. Heiser, PhD, and Mara H. Sherman, PhD share insights on cancer evolution as they preview an upcoming...
Former U.S. Olympic Field Hockey player and cancer survivor Karlie Kisha is running the Philadelphia Marathon to raise money...
The FDA is proposing a cap on nicotine in cigarettes that would reduce the amount by 95%, which could...
Promising early-phase clinical trial data were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
Researchers are exploring innovative early cancer detection strategies involving tiny cancer hunters, the voice, electronic noses, and more.
Since 1993, the American Association for Cancer Research (AACR) has invested more than $542 million in grants to sustain...
A look at recent research on determining breast cancer risk, the impact of lifestyle changes on cancer risk, and...
In October 2025, AACR's journals editors highlighted studies on the anticancer function of an Alzheimer’s-related protein, small-molecule-drug conjugates, and...
Frontiers in Cancer Science 2025 cochairs, Soo Chin Lee and Reshma Taneja, preview this international cancer conference in Singapore.